SNX7 Activators
SNX7 activators are a class of chemical compounds designed to modulate the activity of Sorting Nexin 7 (SNX7), a protein that plays a critical role in intracellular trafficking and endosomal sorting within cells. SNX7 is a member of the Sorting Nexin (SNX) family, which is known for its involvement in membrane trafficking and endocytic pathways. Specifically, SNX7 is associated with the retromer complex, a protein complex involved in the retrieval and recycling of transmembrane proteins from endosomes to the trans-Golgi network or the plasma membrane. This process is essential for maintaining the proper localization and function of various cellular proteins.
SNX7 activators are designed to interact with SNX7 and enhance its role in the retromer complex-mediated sorting of proteins. By targeting SNX7, these compounds may modulate the intracellular trafficking and sorting of transmembrane proteins, impacting various cellular processes. Research on SNX7 activators provides insights into the complex mechanisms that govern intracellular protein trafficking and recycling, shedding light on the importance of these processes for cellular homeostasis and function. Understanding the molecular interactions between SNX7 and its activators is crucial for deciphering the intricate mechanisms of protein sorting and trafficking within cells, contributing to our knowledge of cellular physiology and membrane dynamics. Further investigation is needed to elucidate the precise mechanisms of action and potential biological consequences associated with SNX7 activation, enhancing our understanding of its role in cellular processes related to protein trafficking and membrane dynamics.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA might enhance SNX7 expression by activating protein kinase C, which is involved in various signaling cascades. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin may induce SNX7 expression by elevating cAMP levels, thus activating cAMP-dependent protein kinase A (PKA). | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium might influence SNX7 expression by modulating Wnt/β-catenin signaling pathways. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid could affect SNX7 expression through its role in gene transcription modulation via retinoid receptors. | ||||||
L-3,3′,5-Triiodothyronine, free acid | 6893-02-3 | sc-204035 sc-204035A sc-204035B | 10 mg 100 mg 250 mg | $41.00 $77.00 $153.00 | ||
T3 may regulate SNX7 expression through thyroid hormone receptor-mediated transcriptional regulation. | ||||||
25-Hydroxycholesterol | 2140-46-7 | sc-214091B sc-214091 sc-214091A sc-214091C | 5 mg 10 mg 25 mg 100 mg | $53.00 $91.00 $169.00 $474.00 | 8 | |
This oxysterol might induce SNX7 expression due to its role in lipid metabolism and signaling. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoids could influence SNX7 expression through glucocorticoid receptor-mediated mechanisms. | ||||||
Thymosin β4 | 77591-33-4 | sc-396076 sc-396076A | 1 mg 100 mg | $134.00 $7140.00 | ||
TGF-β might modulate SNX7 expression as part of its broad regulatory effects on cellular growth and differentiation. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin could potentially upregulate SNX7 expression via insulin receptor signaling pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitors might affect SNX7 expression by altering signaling pathways that control protein synthesis and degradation. | ||||||